Tech Company Financing Transactions
Oncodesign Precision Medicine Funding Round
Oncodesign Precision Medicine, based in Dijon, secured $6.9 million from The Michael J. Fox Foundation for Parkinson's Research.
Transaction Overview
Company Name
Announced On
3/3/2026
Transaction Type
Debt
Amount
$6,920,000
Round
Undisclosed
Proceeds Purpose
The current grant supports the CMC work related to the preparation of Drug Product (drug tablets to be used in the studies) for the Phase 1b and the start of Phase 2 studies, starting from the available 67 kgs of GMP Drug Substance (the pure OPM-201 chemical material).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
18 rue Jean Mazen
Dijon, 21000
France
Dijon, 21000
France
Phone
Website
Email Address
Overview
Our mission is to bring innovative therapeutic and diagnostic solutions to treat therapeutic resistance and metastasis evolution. The patient is at the centre of our reflexion, of our unique innovative model, and our investments.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Philippe Genne
Browse more venture capital transactions:
Prev: 3/2/2026: Procode AI venture capital transaction
Next: 3/3/2026: RenoFi venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs